However, the ratio of CD19+HLA-DR+ B cells was similarto that observed in HCs, which indicates that in the later phase of the disease, B cellsare no longer functioning as antigen presenting cells, but as regulatory cells tocontrol the occurrence and development of psoriasis. The gene discussed is CD19; the disease is psoriasis.